Prenatal exposure to a synthetic cannabinoid caused hippocampal memory deficits in adolescent rats by reducing PSA-NCAM (a neural adhesion molecule), which shifted glutamate receptor signaling and impaired synaptic plasticity.
Developmental neuroscientists, prenatal researchers, memory researchers.
Exogenous PSA rescued memory-related synaptic deficits from prenatal cannabinoid exposure
What the researchers found
Prenatal WIN55,212-2 caused hippocampal-dependent memory deficits in adolescent offspring associated with decreased long-term potentiation, enhanced long-term depression, and imbalanced GluN2A/GluN2B signaling. Reduced NCAM and PSA-NCAM expression was identified as the mechanism. Administration of exogenous PSA rescued the LTP deficits, confirming PSA-mediated signaling as the key pathway.
Why it matters
This study identifies a specific and potentially rescuable mechanism for prenatal cannabis-related memory deficits. PSA-NCAM is critical for normal brain plasticity, and finding that its reduction drives the memory impairment opens a door to potential interventions.
The numbers in context
Decreased LTP and enhanced LTD at Schaffer collateral-CA1 synapses. Imbalanced GluN2A/GluN2B signaling. Reduced NCAM and PSA-NCAM. Exogenous PSA rescued LTP deficits.
How the study worked
Prenatal WIN55,212-2 administered to pregnant rats. Adolescent offspring assessed with behavioral tests, electrophysiology (LTP/LTD at hippocampal synapses), and immunochemistry for adhesion molecules and glutamate receptor subunits. Rescue experiment with exogenous PSA.
What this study cannot tell us
Synthetic cannabinoid at controlled dose, not comparable to human cannabis use. Rat brain development timeline differs from humans. Rescue was shown for LTP but broader behavioral recovery not tested. Single timepoint assessment.
How to read the evidence
Mechanistic animal study with a rescue experiment, providing strong pathway evidence but limited to rats.
When this study was published
Published 2023.
The bigger picture
PSA-NCAM is involved in many aspects of brain development and plasticity beyond memory. Its disruption by prenatal cannabinoids could explain a broader range of neurodevelopmental effects. The rescue experiment suggests therapeutic possibilities, though translating this to humans is a long path.
Questions still open
- Could PSA-NCAM levels serve as a biomarker for prenatal cannabis exposure effects?
- Would postnatal interventions targeting PSA-NCAM restore cognitive function?
Common questions
How does prenatal cannabis affect memory?
Can prenatal cannabis memory effects be reversed?
Read the original research
Prenatal Cannabinoid Exposure Elicits Memory Deficits Associated with Reduced PSA-NCAM Expression, Altered Glutamatergic Signaling, and Adaptations in Hippocampal Synaptic Plasticity.
Cells, 12(21)
Citation
Pinky, Priyanka D; Bloemer, Jenna; Smith, Warren D; Du, Yifeng; Heslin, Ryan T; Setti, Sharay E; Pfitzer, Jeremiah C; Chowdhury, Kawsar; Hong, Hao; Bhattacharya, Subhrajit; Dhanasekaran, Muralikrishnan; Dityatev, Alexander; Reed, Miranda N; Suppiramaniam, Vishnu. (2023). Prenatal Cannabinoid Exposure Elicits Memory Deficits Associated with Reduced PSA-NCAM Expression, Altered Glutamatergic Signaling, and Adaptations in Hippocampal Synaptic Plasticity.. Cells, 12(21). https://doi.org/10.3390/cells12212525
Explore the wider topic
- How to Talk to Your Teenager About Weed (Without Losing Them)
- My Kid's Friends Smoke Weed: A Parent's Guide
- I Smoke Weed But Don't Want My Kids To: Navigating the Hypocrisy
- Quitting Weed as a Parent: Why It Is the Hardest and Most Important Quit
- Quitting Weed as a Teen or Young Adult
- My Kid Is Smoking Weed: A Parent's Guide